JP2016515564A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515564A5
JP2016515564A5 JP2016504702A JP2016504702A JP2016515564A5 JP 2016515564 A5 JP2016515564 A5 JP 2016515564A5 JP 2016504702 A JP2016504702 A JP 2016504702A JP 2016504702 A JP2016504702 A JP 2016504702A JP 2016515564 A5 JP2016515564 A5 JP 2016515564A5
Authority
JP
Japan
Prior art keywords
formula
compound
acid
composition
facbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016504702A
Other languages
English (en)
Japanese (ja)
Other versions
JP6500011B2 (ja
JP2016515564A (ja
Filing date
Publication date
Priority claimed from GBGB1305687.4A external-priority patent/GB201305687D0/en
Application filed filed Critical
Publication of JP2016515564A publication Critical patent/JP2016515564A/ja
Publication of JP2016515564A5 publication Critical patent/JP2016515564A5/ja
Application granted granted Critical
Publication of JP6500011B2 publication Critical patent/JP6500011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016504702A 2013-03-28 2014-03-28 放射標識法 Active JP6500011B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1305687.4A GB201305687D0 (en) 2013-03-28 2013-03-28 Radiolabelling process
GB1305687.4 2013-03-28
PCT/EP2014/056344 WO2014154886A1 (en) 2013-03-28 2014-03-28 Radiolabelling process

Publications (3)

Publication Number Publication Date
JP2016515564A JP2016515564A (ja) 2016-05-30
JP2016515564A5 true JP2016515564A5 (enExample) 2017-04-27
JP6500011B2 JP6500011B2 (ja) 2019-04-10

Family

ID=48444922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016504702A Active JP6500011B2 (ja) 2013-03-28 2014-03-28 放射標識法

Country Status (12)

Country Link
US (2) US9999692B2 (enExample)
EP (1) EP2978456B1 (enExample)
JP (1) JP6500011B2 (enExample)
KR (1) KR102218249B1 (enExample)
CN (1) CN105120905B (enExample)
AU (1) AU2014242897B2 (enExample)
CA (1) CA2908029C (enExample)
ES (1) ES2864702T3 (enExample)
GB (1) GB201305687D0 (enExample)
MX (1) MX368061B (enExample)
RU (1) RU2675371C2 (enExample)
WO (1) WO2014154886A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
US20220001034A1 (en) * 2014-06-30 2022-01-06 Ge Healthcare Limited Novel formulation and method of synthesis
GB201621864D0 (en) * 2016-12-21 2017-02-01 Ge Healthcare Ltd Solid phase conditioning

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
AU2006250594B2 (en) * 2005-05-23 2011-06-16 Nihon Medi-Physics Co., Ltd. Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
AU2006262502A1 (en) 2005-06-23 2007-01-04 Emory Univerisity Imaging agents
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
US7897811B2 (en) 2006-05-11 2011-03-01 Nihon Medi-Physics Co., Ltd. Process for production of radioactive fluorine-labeled organic compound
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
US8269035B2 (en) 2007-12-19 2012-09-18 Nihon Medi-Physics Co., Ltd. Process for production of radioactive-fluorine-labeled organic compound
CA2785179C (en) 2009-10-08 2018-06-05 Ge Healthcare Limited Purification method
KR20130132892A (ko) * 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
JP6446268B2 (ja) * 2011-12-21 2018-12-26 ジーイー・ヘルスケア・リミテッド クエン酸緩衝液中の18f−フルシクロビン組成物
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process

Similar Documents

Publication Publication Date Title
JP2022043078A5 (enExample)
JP2017520550A5 (enExample)
JP2012515142A5 (enExample)
JP2013506706A5 (enExample)
JP2016520672A5 (enExample)
JP2013535220A5 (enExample)
JP2012020997A5 (enExample)
JP2013010749A5 (ja) カルバゾール化合物
MX2012010441A (es) Microcapsulas mejoradas y la produccion de estas.
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
CO6231027A2 (es) Metodos e intermediarios para preparar compuestos de lactama lactoma de 8 atomos de carbono activos como inhibidores de renina
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
EP2687505A4 (en) METHOD FOR PRODUCING A DINITRIL COMPOUND
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
AR086451A1 (es) Derivados de 2-amino-3-(imidazol-2-il)piridin-4-ona, preparacion de los mismos y una composicion farmaceutica en base al compuesto
ES2493140T3 (es) Método de síntesis
RU2015138540A (ru) Способ радиоактивного мечения
RU2016128528A (ru) Способы и реактивы для введения радиоактивной метки
WO2015143019A3 (en) Gaseous f-18 technologies
JP2013527149A5 (enExample)
JP2013507343A5 (enExample)
JP2013506705A5 (enExample)
JP2015512436A5 (enExample)
GEP20156350B (en) New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid
MD4392B1 (ro) Procedeu de sinteză a (2E)-3-(3,4-dimetoxifenil)prop-2-ennitrilului şi aplicarea acestuia în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid acceptabil farmaceutic